Therapeutic Implications of Necroptosis Activation in Alzheimer´s Disease

Overview

Journal Alzheimers Res Ther

Date 2024 Dec 26

PMID 39726013

Authors

Elizabeth Carrazana

Natalia Salvadores

Affiliations

Soon will be listed here.

Abstract

In recent years, a growing body of research has unveiled the involvement of the necroptosis pathway in the pathogenesis of Alzheimer's disease (AD). This evidence has shed light on the mechanisms underlying neuronal death in AD, positioning necroptosis at the forefront as a potential target for therapeutic intervention. This review provides an update on the current knowledge on this emerging, yet rapidly advancing topic, encompassing all published studies that present supporting proof of the role of the necroptosis pathway in the neurodegenerative processes of AD. The implication of misfolded tau and amyloid-β (Aβ) aggregates is highlighted, with evidence suggesting their direct or indirect involvement in necroptosis activation. In summary, the review underscores the significance of understanding the complex interplay between necroptosis, protein aggregates, and neurodegeneration in AD. The findings advocate for a comprehensive approach, combining therapeutic and early diagnostic strategies, to intervene in the disease process before irreversible damage occurs.

References

Abdelhady R, Younis N, Ali O, Shehata S, Sayed R, Nadeem R . Cognitive enhancing effects of pazopanib in D‑galactose/ovariectomized Alzheimer's rat model: insights into the role of RIPK1/RIPK3/MLKL necroptosis signaling pathway. Inflammopharmacology. 2023; 31(5):2719-2729. PMC: 10518286. DOI: 10.1007/s10787-023-01269-y. View

Yuan S, Li H, Yang C, Xie W, Wang Y, Zhang J . DHA attenuates Aβ-induced necroptosis through the RIPK1/RIPK3 signaling pathway in THP-1 monocytes. Biomed Pharmacother. 2020; 126:110102. DOI: 10.1016/j.biopha.2020.110102. View

Li X, Lang X, Ren T, Wang J, Lan R, Qin X . Coeloglossum viride var. bracteatum extract attenuates Aβ-induced toxicity by inhibiting RIP1-driven inflammation and necroptosis. J Ethnopharmacol. 2021; 282:114606. DOI: 10.1016/j.jep.2021.114606. View

Xu C, Wu J, Wu Y, Ren Z, Yao Y, Chen G . TNF-α-dependent neuronal necroptosis regulated in Alzheimer's disease by coordination of RIPK1-p62 complex with autophagic UVRAG. Theranostics. 2021; 11(19):9452-9469. PMC: 8490500. DOI: 10.7150/thno.62376. View

Mehta D, Jackson R, Paul G, Shi J, Sabbagh M . Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015. Expert Opin Investig Drugs. 2017; 26(6):735-739. PMC: 5576861. DOI: 10.1080/13543784.2017.1323868. View

Dondelinger Y, Declercq W, Montessuit S, Roelandt R, Goncalves A, Bruggeman I . MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell Rep. 2014; 7(4):971-81. DOI: 10.1016/j.celrep.2014.04.026. View

Hendriks L, van Duijn C, Cras P, Cruts M, Van Hul W, Van Harskamp F . Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet. 1992; 1(3):218-21. DOI: 10.1038/ng0692-218. View

Brokaw D, Piras I, Mastroeni D, Weisenberger D, Nolz J, Delvaux E . Cell death and survival pathways in Alzheimer's disease: an integrative hypothesis testing approach utilizing -omic data sets. Neurobiol Aging. 2020; 95:15-25. PMC: 7609561. DOI: 10.1016/j.neurobiolaging.2020.06.022. View

Sun Y, Xu L, Shao H, Quan D, Mo Z, Wang J . Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer's Disease. J Med Chem. 2022; 65(21):14957-14969. DOI: 10.1021/acs.jmedchem.2c01478. View

10.

Moonen S, Koper M, Van Schoor E, Schaeverbeke J, Vandenberghe R, von Arnim C . Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons. Acta Neuropathol. 2022; 145(2):175-195. DOI: 10.1007/s00401-022-02528-y. View

11.

Moujalled D, Strasser A, Liddell J . Molecular mechanisms of cell death in neurological diseases. Cell Death Differ. 2021; 28(7):2029-2044. PMC: 8257776. DOI: 10.1038/s41418-021-00814-y. View

12.

Cras P, Kawai M, Lowery D, Greenberg B, Perry G . Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein. Proc Natl Acad Sci U S A. 1991; 88(17):7552-6. PMC: 52339. DOI: 10.1073/pnas.88.17.7552. View

13.

Zou C, Mifflin L, Hu Z, Zhang T, Shan B, Wang H . Reduction of mNAT1/hNAT2 Contributes to Cerebral Endothelial Necroptosis and Aβ Accumulation in Alzheimer's Disease. Cell Rep. 2020; 33(10):108447. DOI: 10.1016/j.celrep.2020.108447. View

14.

Koper M, Moonen S, Ronisz A, Ospitalieri S, Callaerts-Vegh Z, TSyen D . Inhibition of an Alzheimer's disease-associated form of necroptosis rescues neuronal death in mouse models. Sci Transl Med. 2024; 16(771):eadf5128. DOI: 10.1126/scitranslmed.adf5128. View

15.

Stokin G, Lillo C, Falzone T, Brusch R, Rockenstein E, Mount S . Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease. Science. 2005; 307(5713):1282-8. DOI: 10.1126/science.1105681. View

16.

Wang W, Gu X, Cheng Z, Lu X, Xie S, Liu X . IKKβ Alleviates Neuron Injury in Alzheimer's Disease via Regulating Autophagy and RIPK1-Mediated Necroptosis. Mol Neurobiol. 2022; 59(4):2407-2423. DOI: 10.1007/s12035-021-02652-y. View

17.

Farrer L, Cupples L, Haines J, Hyman B, Kukull W, Mayeux R . Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997; 278(16):1349-56. View

18.

Caccamo A, Branca C, Piras I, Ferreira E, Huentelman M, Liang W . Necroptosis activation in Alzheimer's disease. Nat Neurosci. 2017; 20(9):1236-1246. DOI: 10.1038/nn.4608. View

19.

Jayaraman A, Htike T, James R, Picon C, Reynolds R . TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer's disease hippocampus. Acta Neuropathol Commun. 2021; 9(1):159. PMC: 8501605. DOI: 10.1186/s40478-021-01264-w. View

20.

Selkoe D, Hardy J . The amyloid hypothesis of Alzheimer's disease at 25 years. EMBO Mol Med. 2016; 8(6):595-608. PMC: 4888851. DOI: 10.15252/emmm.201606210. View